![](/img/cover-not-exists.png)
P.11.15 Recombinant human insulin-like growth factor-I (IGF-I) therapy in Duchenne Muscular Dystrophy (DMD): A 6-month prospective randomized controlled trial
Rutter, M.M., Collins, J., Backeljauw, P.F., Horn, P., Taylor, M.D., Hu, S.Y., Blum, S., Morehart, P., Sawnani, H., Wong, B.L.Volume:
23
Language:
english
Journal:
Neuromuscular Disorders
DOI:
10.1016/j.nmd.2013.06.576
Date:
October, 2013
File:
PDF, 49 KB
english, 2013